Dr Reddys Price to Sales

<div class='logoBackup' style='background:#754DEB;color: white;font-size:4em;padding-top: 15px;;'>DR</div>
RDY -- USA Stock  

USD 42.42  1.16  2.81%

Dr Reddys price-to-sales fundamental analysis lookup allows you to check this and other indicators for Dr Reddys Laboratories Ltd or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
Symbol
Refresh

Dr Reddys Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis
Dr Reddys Price to Sales  =
2.86 
ValuationFundamentalsBuy or Sell

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition
Based on latest financial disclosure the price to sales indicator of Dr Reddys Laboratories Ltd is roughly 2.86 times. This is 86.64% lower than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?Specialty & Generic industry, The Price to Sales for all stocks is 74.96% higher than the company.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Dr Reddys current financial ratios